X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1105) 1105
fms-like tyrosine kinase 3 - genetics (657) 657
fms-like tyrosine kinase 3 - metabolism (628) 628
animals (595) 595
hematology (539) 539
mice (476) 476
female (427) 427
mutation (415) 415
leukemia, myeloid, acute - genetics (412) 412
oncology (377) 377
acute myeloid-leukemia (354) 354
male (333) 333
internal tandem duplication (300) 300
leukemia, myeloid, acute - metabolism (299) 299
adult (266) 266
fms-like tyrosine kinase 3 - antagonists & inhibitors (264) 264
leukemia, myeloid, acute - drug therapy (262) 262
flt3 (248) 248
leukemia (238) 238
acute myeloid leukemia (237) 237
fms-like tyrosine kinase 3 (236) 236
hemic and lymphatic diseases (234) 234
leukemia, myeloid, acute - pathology (234) 234
middle aged (225) 225
cell line, tumor (221) 221
mutations (207) 207
expression (193) 193
signal transduction (186) 186
aged (179) 179
aml (174) 174
prognosis (172) 172
acute myelogenous leukemia (169) 169
embryonic structures (169) 169
tyrosine (169) 169
phosphorylation (162) 162
cancer (159) 159
protein kinase inhibitors - pharmacology (159) 159
hemic and immune systems (156) 156
antineoplastic agents - pharmacology (137) 137
mice, inbred c57bl (135) 135
apoptosis - drug effects (134) 134
proto-oncogene proteins - genetics (134) 134
proto-oncogene proteins - metabolism (134) 134
apoptosis (132) 132
research (127) 127
gene expression (126) 126
abridged index medicus (122) 122
cell biology (122) 122
gene (122) 122
flow cytometry (119) 119
adolescent (118) 118
cells, cultured (118) 118
receptor protein-tyrosine kinases - metabolism (118) 118
cell proliferation (115) 115
cell proliferation - drug effects (115) 115
receptor protein-tyrosine kinases - genetics (114) 114
kinases (112) 112
nuclear proteins - genetics (112) 112
analysis (111) 111
activation (110) 110
tandem repeat sequences (108) 108
immunology (105) 105
aged, 80 and over (103) 103
cells (103) 103
fluids and secretions (101) 101
signal transduction - drug effects (99) 99
leukemia, myeloid, acute - enzymology (97) 97
cell line (96) 96
tyrosine kinase inhibitor (96) 96
acute disease (93) 93
antineoplastic agents - therapeutic use (93) 93
medicine, research & experimental (92) 92
tumor cells, cultured (92) 92
genetic aspects (90) 90
constitutive activation (89) 89
dendritic cells (88) 88
gene expression regulation, leukemic (87) 87
biochemistry & molecular biology (86) 86
chemotherapy (84) 84
hematopoietic stem cells - cytology (84) 84
in-vitro (84) 84
young adult (84) 84
leukemia, myeloid, acute - mortality (83) 83
proteins (83) 83
hematopoietic stem cells - metabolism (81) 81
identification (81) 81
differentiation (79) 79
reverse transcriptase polymerase chain reaction (79) 79
stem-cells (79) 79
flt3-itd (78) 78
hematology, oncology and palliative medicine (78) 78
mutation - genetics (78) 78
pregnancy (77) 77
myeloid leukemia (74) 74
blotting, western (73) 73
child (73) 73
in-vivo (73) 73
protein kinase inhibitors - therapeutic use (72) 72
stem cells (72) 72
mice, knockout (71) 71
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1324) 1324
Chinese (19) 19
Japanese (3) 3
German (1) 1
Norwegian (1) 1
Russian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of immunology (1950), ISSN 1550-6606, 2005, Volume 174, Issue 11, pp. 6592 - 6597
Journal Article
The Journal of biological chemistry, ISSN 1083-351X, 2011, Volume 286, Issue 13, pp. 10918 - 10929
Journal Article
PloS one, ISSN 1932-6203, 10/2012, Volume 7, Issue 10, p. e47668
... is negatively regulated by p53 [3] and positively regulated by STAT3 [4] and TCF-4 [5]. Similar to human protein, full-length murine survivin (survivin140) contains... 
PROGENITOR CELLS | APOPTOSIS | EXTRACELLULAR SURVIVIN | COLORECTAL-CANCER | MULTIDISCIPLINARY SCIENCES | IN-VIVO | DENDRITIC CELL-DEVELOPMENT | RECEPTOR | FLT3 LIGAND | INHIBITOR | HEMATOPOIETIC STEM | fms-Like Tyrosine Kinase 3 - antagonists & inhibitors | Inhibitor of Apoptosis Proteins - genetics | Humans | Middle Aged | Male | Membrane Proteins - pharmacology | Spleen - drug effects | Young Adult | Bone Marrow - metabolism | Aged, 80 and over | Adult | Female | Inhibitor of Apoptosis Proteins - metabolism | Repressor Proteins - metabolism | Bone Marrow - drug effects | Disease Models, Animal | Alternative Splicing - genetics | Repressor Proteins - genetics | Arthritis, Rheumatoid - enzymology | Down-Regulation - drug effects | Enzyme Activation - drug effects | fms-Like Tyrosine Kinase 3 - metabolism | Arthritis, Rheumatoid - pathology | Up-Regulation - drug effects | Alternative Splicing - drug effects | Animals | Signal Transduction - drug effects | Spleen - metabolism | Aged | Mice | Mice, Inbred BALB C | RNA, Small Interfering - metabolism | Tyrosine | Care and treatment | Dendritic cells | Rheumatoid arthritis | Research | Survivin | Gene expression | Apoptosis | Alternative splicing | Transcription | Leukemia | Arthritis | Leukocytes | Kinases | Proteins | Cell growth | Cell cycle | Bone marrow | Protein-tyrosine kinase | Chromosomes | Spleen | Antigens | FLT3L protein | Cell survival | Cytokines | Rheumatology | Cell division | Inflammation | Joint diseases | Patients | White blood cells | Signaling | Inhibitors | Medical prognosis | Stem cells | Ligands | Flt3 protein | Mutation | Rheumatoid | Disease Models | Up-Regulation | Inbred BALB C | pathology | Alternative Splicing | RNA | Repressor Proteins | fms-Like Tyrosine Kinase 3 | Immunologi inom det medicinska området | 80 and over | genetics | pharmacology | Bone Marrow | Immunology in the medical area | Inhibitor of Apoptosis Proteins | Small Interfering | Signal Transduction | Down-Regulation | drug effects | enzymology | antagonists & inhibitors | Membrane Proteins | Animal | metabolism | Enzyme Activation
Journal Article
Molecular cancer, ISSN 1476-4598, 2013, Volume 12, Issue 1, pp. 19 - 19
Background: Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example... 
PDGFR | Quizartinib | FLT3 | AC220 | Leukemia | KIT | WILD-TYPE | GASTROINTESTINAL STROMAL TUMOR | LIGAND-INDEPENDENT ACTIVATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | C-KIT | ACUTE MYELOID-LEUKEMIA | MYELODYSPLASTIC SYNDROME | SYSTEMIC MASTOCYTOSIS | ONCOLOGY | FLT3 GENE | INTERNAL TANDEM DUPLICATIONS | MAST-CELL LEUKEMIA | fms-Like Tyrosine Kinase 3 - antagonists & inhibitors | Phosphorylation | Apoptosis - drug effects | Humans | Apoptosis - genetics | Leukemia - metabolism | Proto-Oncogene Proteins c-kit - metabolism | Proto-Oncogene Proteins c-kit - antagonists & inhibitors | Dose-Response Relationship, Drug | fms-Like Tyrosine Kinase 3 - genetics | Receptor, Platelet-Derived Growth Factor alpha - antagonists & inhibitors | Inhibitory Concentration 50 | Proto-Oncogene Proteins c-kit - genetics | Antineoplastic Agents - pharmacology | Gastrointestinal Stromal Tumors - genetics | Leukemia - genetics | Receptor, Platelet-Derived Growth Factor alpha - metabolism | Benzothiazoles - pharmacology | fms-Like Tyrosine Kinase 3 - metabolism | Receptor, Platelet-Derived Growth Factor alpha - genetics | Protein Isoforms | Cell Line, Tumor | Gastrointestinal Stromal Tumors - metabolism | Cell Proliferation - drug effects | Phenylurea Compounds - pharmacology | Protein Kinase Inhibitors - pharmacology | Mutation | Tyrosine | Medical research | Platelet-derived growth factor | Codon | Analysis | Medicine, Experimental | Phenols
Journal Article
Leukemia, ISSN 1476-5551, 2007, Volume 21, Issue 8, pp. 1658 - 1668
...) kinases, with significantly less activity against other tyrosine kinases including JAK3 (IC50 = 169 nM... 
MYELOFIBROSIS | JAK2(V617F) | POLYCYTHEMIA-VERA | ESSENTIAL THROMBOCYTHEMIA | JAK2V617F | myeloproliferative disorder | mutation | kinase inhibitor | MEGAKARYOBLASTIC LEUKEMIA | ACTIVATING MUTATION | ONCOLOGY | V617F | ACUTE LYMPHOBLASTIC-LEUKEMIA | JAK2 | HEMATOLOGY | MYELOID METAPLASIA | fms-Like Tyrosine Kinase 3 - antagonists & inhibitors | Apoptosis - drug effects | Humans | STAT Transcription Factors - metabolism | Polycythemia Vera - genetics | Myeloproliferative Disorders - genetics | Janus Kinase 3 - antagonists & inhibitors | Polycythemia Vera - metabolism | fms-Like Tyrosine Kinase 3 - genetics | Janus Kinase 2 - metabolism | Myeloproliferative Disorders - metabolism | Colony-Forming Units Assay | Phosphorylation - drug effects | Janus Kinase 3 - metabolism | Janus Kinase 2 - antagonists & inhibitors | Primary Myelofibrosis - metabolism | Primary Myelofibrosis - drug therapy | Thrombopoietin - metabolism | Enzyme Inhibitors - pharmacology | Janus Kinase 2 - genetics | Myeloproliferative Disorders - drug therapy | Pyrimidines - pharmacology | Mice, SCID | Mutation - genetics | Sulfonamides - pharmacology | Receptors, Thrombopoietin - metabolism | Receptors, Thrombopoietin - antagonists & inhibitors | fms-Like Tyrosine Kinase 3 - metabolism | Receptors, Thrombopoietin - genetics | Primary Myelofibrosis - genetics | Animals | Janus Kinase 3 - genetics | Stem Cells - drug effects | Polycythemia Vera - drug therapy | Cell Proliferation - drug effects | Mice | Cell Cycle - drug effects | Antibody diversity | Chemical inhibitors | Genetic aspects | Research | Health aspects | Myeloproliferative disorders
Journal Article
Nature communications, ISSN 2041-1723, 2018, Volume 9, Issue 1, pp. 1042 - 13
Journal Article
American journal of obstetrics and gynecology, ISSN 0002-9378, 2016, Volume 214, Issue 3, pp. 356.e1 - 356.e15
Journal Article
Journal Article
Leukemia, ISSN 1476-5551, 2014, Volume 29, Issue 3, pp. 535 - 547
Journal Article